Paul G. Chaney, Director at EYEGATE PHARMACEUTICALS INC (EYEG), bought 8,333 shares at $6.00 ($50K) on 2015-02-19, disclosed to the SEC on 2015-02-23.
Open-market purchase of $50k EYEG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.